Ketoconazole for Dogs: Dosage, Fungal Infections & Liver Safety

Ketoconazole is an azole antifungal used in dogs for selected fungal and yeast infections, including some systemic mycoses and certain difficult skin or ear infections. It is also sometimes used for non-antifungal reasons because it can inhibit steroid-hormone synthesis and alter metabolism of other drugs. Those additional effects are exactly why ketoconazole needs careful prescribing and monitoring rather than being treated as a simple “strong antifungal.”

Dog Medication Math Calculator

Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.

Dose information from your veterinarian

Optional liquid conversion

Use the exact concentration printed on the current bottle. Different refills can have different strengths.
Safety check: This tool performs arithmetic only. It does not decide whether a drug is appropriate, choose a dose, frequency or duration, or replace a veterinarian. If the entered dose or concentration does not exactly match the prescription, stop and verify it before giving medication. See Dog Weight Converter and Dog Liquid Medication mg-to-mL Calculator.

Compared with newer azoles such as itraconazole and fluconazole, ketoconazole is more likely to cause gastrointestinal upset and liver-related adverse effects, and its absorption is more dependent on stomach acidity. It still has a useful veterinary role, especially when the target organism is susceptible and the clinician wants a familiar, relatively affordable oral azole.

How ketoconazole works

Ketoconazole inhibits fungal cytochrome P450 enzymes involved in synthesis of ergosterol, an essential component of fungal cell membranes. Without normal ergosterol production, the fungal membrane becomes dysfunctional and growth is inhibited.

The same broad enzyme-inhibition property can affect mammalian steroid and drug metabolism. That is why ketoconazole has more endocrine and interaction effects than many owners expect from an antifungal.

Which fungal infections may be treated?

Ketoconazole has activity against a range of yeasts and fungi, including organisms associated with blastomycosis, histoplasmosis, coccidioidomycosis, candidiasis and some dermatophyte infections. Choice of drug depends on the organism, disease location, severity and current susceptibility patterns.

Merck Veterinary Manual notes that itraconazole and fluconazole have largely become more prominent for many systemic mycoses because of their pharmacokinetic and tolerability advantages. Ketoconazole remains relevant but is not automatically the best first choice for every fungal disease.

Skin and yeast disease

Dogs with Malassezia dermatitis or chronic yeast-associated skin disease may receive topical therapy, systemic therapy or both. Ketoconazole can be used when disease is widespread or topical treatment alone is insufficient.

Before assuming yeast is the only problem, the veterinarian should address the reason it keeps recurring. Allergic skin disease, endocrine disease, abnormal skin folds and chronic inflammation can all create conditions in which yeast repeatedly overgrows.

Ear infections

Ketoconazole appears in some topical combinations used for canine otitis, but oral ketoconazole is not a routine substitute for ear cytology and local treatment. Bacterial infection, resistant organisms, foreign material, ear-canal narrowing and middle-ear disease can all change the plan.

An ear that keeps relapsing deserves investigation of the underlying cause, not repeated antifungal courses alone.

Systemic fungal disease requires a diagnosis

Deep fungal infections can affect lungs, bones, eyes, lymph nodes, skin, brain or multiple organs. Signs are often nonspecific: weight loss, fever, cough, lameness, eye disease or enlarged lymph nodes.

Because treatment can last for months and azoles have meaningful adverse effects, diagnosis may involve cytology, histopathology, fungal antigen testing, culture, imaging or combinations of these tests.

Food can improve absorption

Ketoconazole absorption is better in an acidic stomach and often improves when given with food. Drugs that reduce gastric acidity can reduce absorption and make treatment less reliable.

If the dog is also taking omeprazole, famotidine or another acid-suppressing medicine, tell the veterinarian. The timing or choice of antifungal may need reconsideration.

Ketoconazole dosage by weight: fungal use depends on the disease

Merck’s general azole table lists ketoconazole in dogs at 5–20 mg/kg by mouth every 12 hours. Its integumentary-disease guidance uses narrower regimens for specific problems, including 10 mg/kg once daily for several skin and yeast indications. The diagnosis and duration are therefore part of the dose context.

Reference contextPublished canine guidanceKey limitation
General azole pharmacology5–20 mg/kg PO every 12 hoursBroad reference range
Selected skin / yeast disease10 mg/kg PO every 24 hoursDisease-specific context
AbsorptionRequires acidic gastric environmentAcid suppressants can reduce absorption

See the Merck azole reference and Merck integumentary antifungal guidance. Because ketoconazole can affect the liver and steroid synthesis, weight is only one part of safe prescribing.

Gastrointestinal side effects are common

Vomiting, diarrhea and reduced appetite are among the most frequent reasons dogs struggle with oral ketoconazole. Giving the medicine with food may improve tolerance in some patients, but persistent appetite loss should not simply be ignored through a long treatment course.

Weight loss during antifungal therapy can reflect the underlying infection, drug intolerance or both. Keep the veterinary team informed if eating deteriorates.

Liver toxicity

Azoles can raise liver enzymes, and ketoconazole is particularly associated with hepatic adverse effects. Most mild enzyme changes do not automatically mean severe liver failure, but they should be interpreted in context.

Call the veterinarian for persistent vomiting, profound appetite loss, yellow gums or eyes, dark urine, unusual bruising or marked lethargy. Dogs receiving prolonged therapy may need periodic chemistry panels.

Why baseline bloodwork helps

Systemic fungal disease itself can affect organs, and many affected dogs will be treated for weeks or months. Baseline liver and kidney values give the veterinarian something to compare with later results if appetite or energy changes.

A dog with pre-existing liver disease may be better suited to another antifungal depending on the infection and alternatives available.

Ketoconazole affects steroid hormones

Ketoconazole can inhibit adrenal and gonadal steroid synthesis. This pharmacology has been used therapeutically in some endocrine conditions, but it can also produce unwanted hormonal effects.

At antifungal doses, clinically important adrenal suppression is less predictable than with drugs specifically used for Cushing’s disease, yet the possibility adds to the reason prolonged use should be supervised.

Why ketoconazole was historically used for Cushing’s disease

Before trilostane became widely used, ketoconazole was sometimes prescribed to suppress cortisol production in dogs with hyperadrenocorticism. Response can be inconsistent, and modern endocrine references generally favor more targeted therapies.

Do not repurpose leftover ketoconazole for a dog suspected of having Cushing’s disease. Diagnosis and an endocrine-specific treatment plan are needed.

Drug interactions are a major issue

Ketoconazole inhibits hepatic drug-metabolizing enzymes, particularly CYP pathways. That can increase exposure to other medications and prolong their effects.

Give the veterinarian a complete list that includes behavior medicines, heart drugs, seizure medicines, steroids, immunosuppressants and supplements. A medicine that was previously well tolerated may behave differently once ketoconazole is added.

Cyclosporine interaction

Ketoconazole can substantially increase cyclosporine concentrations by reducing its metabolism. Veterinarians have sometimes used that interaction deliberately to reduce the amount of cyclosporine required, but it must be planned.

Do not combine the two independently to save medication costs. Excess cyclosporine exposure can increase adverse effects and immunosuppression.

Ketoconazole and corticosteroids

Because ketoconazole can affect steroid synthesis and metabolism, concurrent glucocorticoid treatment deserves review. The combined endocrine and hepatic effects can complicate interpretation of weakness, appetite changes and laboratory results.

Never stop chronic prednisone abruptly simply because ketoconazole has been started.

Ketoconazole and anticonvulsants

Some seizure medicines induce liver enzymes and can lower azole concentrations, while ketoconazole can affect metabolism of other anticonvulsants. Dogs with epilepsy and fungal disease may therefore require closer review of both treatment plans.

Tell the veterinarian about phenobarbital, zonisamide, levetiracetam and any other seizure medication before antifungal therapy begins.

What if a dose is missed?

Do not double the next dose automatically. Long antifungal courses rely on consistent exposure, but two doses close together can worsen gastrointestinal or hepatic adverse effects.

Follow the missed-dose guide for the general principle and contact the clinic if several doses have been missed.

What if an extra dose is given?

An accidental extra dose most often raises concern for gastrointestinal upset and increased drug-interaction or hepatic effects. Contact the veterinarian with the tablet strength, amount involved, dog’s weight and all concurrent medicines.

A large ingestion deserves prompt advice even if the dog initially appears normal.

Ketoconazole versus itraconazole

Itraconazole has a broad antifungal spectrum and is often preferred for many systemic fungal infections because it is generally better tolerated and has favorable tissue distribution. Ketoconazole may still be chosen based on cost, organism, clinician experience and disease location.

They should not be swapped tablet-for-tablet. Their pharmacokinetics and formulations differ.

Ketoconazole versus fluconazole

Fluconazole penetrates the central nervous system and urine particularly well, making it useful for certain disease locations. It is less active against some organisms, including Aspergillus, than itraconazole or ketoconazole.

The best antifungal is therefore not simply the newest or most expensive; it depends on where the infection is and which organism is involved.

Ketoconazole versus terbinafine

Terbinafine works at a different step of ergosterol synthesis and is often used for dermatophytes or as part of selected combination strategies. It does not carry the same CYP inhibition profile as ketoconazole.

Combination antifungal therapy is sometimes used for difficult disease, but it also increases complexity and should be guided by veterinary evidence rather than internet experimentation.

Dermatophyte infection and environmental control

When ketoconazole is used for ringworm, medication is only one part of management. Infected hairs and spores contaminate the environment and can spread to other animals and people.

Veterinary guidance may include topical therapy, environmental cleaning, treatment of exposed animals and confirmation that infection has resolved before stopping control measures.

Fungal infections can require months of therapy

Systemic mycoses often need prolonged treatment after clinical signs improve. Stopping as soon as coughing or skin lesions disappear can allow relapse.

The veterinarian may use imaging, antigen testing, cytology or other measures to decide when treatment has been long enough.

Why resistance and species identification matter

Not all fungi respond equally to all azoles. Resistance can occur, particularly after prior exposure. If disease progresses despite apparently appropriate treatment, organism identification and susceptibility information may change the plan.

Increasing the dose without reassessment can add toxicity while leaving an ineffective drug in place.

Pregnancy and breeding animals

Azole antifungals can affect steroid synthesis and fetal development. Breeding, pregnant and nursing animals require individualized risk assessment.

Do not use ketoconazole left over from another dog in a pregnant animal without veterinary direction.

Handling long-term medication

Keep tablets in the original labeled container and protect them from moisture and heat according to the pharmacy instructions. Use a written schedule for multi-month courses.

If the pharmacy changes manufacturer or strength, confirm the number of tablets before the next dose.

When appetite loss becomes a treatment problem

A mild temporary decrease in appetite may be manageable, but persistent food refusal is important in a dog fighting a systemic fungal infection. Malnutrition slows recovery and may signal liver or gastrointestinal toxicity.

Contact the clinic rather than relying on appetite stimulants to cover a worsening adverse effect.

Monitoring during prolonged therapy

Depending on the disease and dog, follow-up may include body weight, liver enzymes, bilirubin, complete blood count and tests that track fungal burden. The schedule is individualized.

Bring a note of any vomiting, diarrhea, appetite change, new medication or supplement to each recheck so laboratory trends are interpreted properly.

Questions to ask before starting

Ask what organism is suspected or confirmed, why ketoconazole was chosen over itraconazole or fluconazole, how long treatment is expected to last, whether food improves absorption and when liver values should be rechecked.

Also ask whether any current antacid, seizure medicine, behavior medicine or immunosuppressant creates an important interaction.

Reliable references

The Merck Veterinary Manual azole antifungal review describes ketoconazole’s spectrum, absorption, adverse effects and interaction potential. Disease-specific fungal guidance should determine whether ketoconazole is appropriate for a particular mycosis.

Bottom line

Ketoconazole remains a useful canine antifungal, but it is not the default choice for every fungal infection. Its practical limitations include gastrointestinal upset, liver effects, dependence on gastric acidity and significant drug interactions.

Use it only for a diagnosed or strongly suspected fungal problem, give it consistently as directed, report appetite loss or vomiting, and keep the veterinary team informed about every other medication the dog receives.

DogMedsHub provides source-backed canine medication guidance and does not diagnose, prescribe or replace veterinary care.

Why stomach-acid suppression matters so much

Ketoconazole dissolves and absorbs better in an acidic gastric environment. Dogs taking proton-pump inhibitors or H2 blockers may absorb less of it, which can make a seemingly adequate prescription less effective. This is especially important in systemic fungal disease where underexposure can allow infection to persist for months.

Do not stop an acid-suppressing medicine abruptly if it was prescribed for a serious gastrointestinal condition. Instead, tell the veterinarian managing the fungal infection. A different antifungal may be more reliable than trying to manipulate stomach acidity without a clear plan.

Why liver-enzyme elevation is not a diagnosis by itself

Dogs with systemic fungal disease, Cushing’s disease, concurrent medications or chronic inflammation may already have elevated liver enzymes before ketoconazole starts. A later rise does not automatically prove severe drug injury. The pattern, magnitude, bilirubin, appetite and clinical signs all matter.

The useful comparison is the dog’s baseline. If the veterinarian has pretreatment chemistry results, later changes can be interpreted more intelligently than an isolated “high ALT” flag.

Can ketoconazole be used with topical antifungals?

Yes. Combining oral and topical therapy can be useful in extensive skin or yeast disease because topical products reduce organism load at the skin surface while systemic medicine reaches deeper sites. Shampoos, wipes, mousses or ear products may therefore be part of the same plan.

That does not mean more products are always better. Excessive bathing can irritate compromised skin, and topical ingredients can be inappropriate for damaged ear drums. Follow the dermatologist or primary veterinarian’s instructions rather than adding multiple antifungal products independently.

What happens when treatment appears to fail?

Apparent failure can come from the wrong diagnosis, an organism that is not susceptible, inadequate absorption, inconsistent dosing, drug interaction, poor penetration into the infected tissue or stopping treatment too soon. In dermatology, an untreated allergy can also make “yeast treatment failure” look worse because the skin environment remains abnormal.

Before escalating the dose, the veterinarian may repeat cytology, culture, antigen testing or imaging and review how the medicine has actually been administered.

Why geographic fungal disease matters

Systemic mycoses are not distributed evenly. Blastomycosis, histoplasmosis and coccidioidomycosis have different geographic patterns and environmental exposures. Travel history can therefore be diagnostically important even when the dog became ill weeks or months after exposure.

Tell the veterinarian about prior residence and travel, not only the current city. That information can influence which fungal tests are sensible and which antifungal is preferred.

Eye involvement changes urgency

Some systemic fungal diseases can affect the eyes and threaten vision. Redness, squinting, cloudiness, sudden vision change or abnormal pupils in a dog being treated for a deep fungal infection deserve prompt examination.

Drug penetration into ocular tissues differs between antifungals, and local ophthalmic treatment may be needed. Do not assume oral ketoconazole alone covers every ocular manifestation.

Central nervous system fungal disease

When fungal infection involves the brain or spinal cord, drug penetration across the blood-brain barrier becomes important. Fluconazole is often favored in some CNS situations because of its distribution characteristics.

New seizures, circling, behavior change, neck pain or weakness in a dog with a systemic mycosis should trigger urgent reassessment rather than a routine refill.

Why long courses should still be periodically questioned

Months of therapy can become automatic. At each recheck, the useful questions are whether the infection is objectively improving, whether the dog is tolerating the drug, whether the original diagnosis still fits and what endpoint will be used to stop treatment.

Continuing indefinitely without a defined treatment goal exposes the dog to cost and adverse effects without proving benefit.

Share